Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

Antiretroviral Therapy Cohort Collaboration (ART-CC)., Mugavero MJ, May M, Harris R, Saag MS, Costagliola D, Egger M, Phillips A, Günthard HF, Dabis F, Hogg R, de Wolf F, Fatkenheuer G, Gill MJ, Justice A, D'Arminio Monforte A, Lampe F, Miró JM, Staszewski S, Sterne JA.

AIDS. 2008 Nov 30;22(18):2481-92. doi: 10.1097/QAD.0b013e328318f130.

2.

Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?

Reekie J, Mocroft A, Sambatakou H, Machala L, Chiesi A, van Lunzen J, Clumeck N, Kirk O, Gazzard B, Lundgren JD; EuroSIDA Study Group..

AIDS. 2008 Nov 12;22(17):2381-90. doi: 10.1097/QAD.0b013e328317a6eb.

PMID:
18981778
3.

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.

Monforte Ad, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, Kirk O, Law M, De Wit S, Friis-Møller N, Phillips AN, Sabin CA, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group..

AIDS. 2008 Oct 18;22(16):2143-53. doi: 10.1097/QAD.0b013e3283112b77.

4.

Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction.

Data Collection on Adverse Events of Anti-HIV Drugs Study Group., Sabin CA, d'Arminio Monforte A, Friis-Moller N, Weber R, El-Sadr WM, Reiss P, Kirk O, Mercie P, Law MG, De Wit S, Pradier C, Phillips AN, Lundgren JD.

Clin Infect Dis. 2008 Apr 1;46(7):1101-10. doi: 10.1086/528862.

5.

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

D:A:D Study Group., Sabin CA, Worm SW, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, D'Arminio Monforte A, Friis-Møller N, Kirk O, Pradier C, Weller I, Phillips AN, Lundgren JD.

Lancet. 2008 Apr 26;371(9622):1417-26. doi: 10.1016/S0140-6736(08)60423-7. Erratum in: Lancet. 2008 Jul 26;372(9635):292.

6.

Recommendations from SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA on nutrition in the HIV-infected patient.

Polo R, Gómez-Candela C, Miralles C, Locutura J, Alvarez J, Barreiro F, Bellido D, Câncer E, Cánoves D, Domingo P, Estrada V, Fumaz CR, Galindo MJ, García-Benayas T, Iglesias C, Irles JA, Jiménez-Nacher I, Lozano F, Marqués I, Martínez-Alvarez JR, Mellado MJ, Miján A, Ramos JT, Riobo P; SPNS/GEAM/SENBA/SENPE/AEDN/SEDCA/GESIDA..

Nutr Hosp. 2007 Mar-Apr;22(2):229-43. Review.

PMID:
17416041
7.

Rate of virologic failure and selection of drug resistance mutations using different triple nucleos(t)ide analogue combinations in HIV-infected patients.

Martín-Carbonero L, Gil P, García-Benayas T, Barreiro P, Blanco F, de Mendoza C, Maida I, González-Lahoz J, Soriano V.

AIDS Res Hum Retroviruses. 2006 Dec;22(12):1231-5.

PMID:
17209764
8.

Cyclosporiasis: a point source outbreak acquired in Guatemala.

Puente S, Morente A, García-Benayas T, Subirats M, Gascón J, González-Lahoz JM.

J Travel Med. 2006 Nov-Dec;13(6):334-7.

9.

[Role of bone gammagraphy in the diagnosis of secondary osteomalacia in a patient treated with tenofovir].

Torres Isidro MV, García Benayas T, del Val Gómez Martínez M, González Gallardo F, Gambí Pisonero N, Castilla Miguel S, González-Lahoz J, Gallego Sanz D.

Rev Esp Med Nucl. 2006 Mar-Apr;25(2):103-6. Spanish.

10.

Higher risk of hyperglycemia in HIV-infected patients treated with didanosine plus tenofovir.

García-Benayas T, Rendón AL, Rodríguez-Novóa S, Barrios A, Maida I, Blanco F, Barreiro P, Rivas P, González-Lahoz J, Soriano V.

AIDS Res Hum Retroviruses. 2006 Apr;22(4):333-7.

PMID:
16623636
11.

Nucleoside/nucleotide backbones for the treatment of HIV infection.

Barreiro P, Jiménez-Nácher I, García B, García-Benayas T, Rivas P, Soriano V.

Curr Opin Investig Drugs. 2005 Aug;6(8):812-22. Review.

PMID:
16121688
12.

Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine.

Barrios A, Rendón A, Negredo E, Barreiro P, Garcia-Benayas T, Labarga P, Santos J, Domingo P, Sánchez-Conde M, Maida I, Martín-Carbonero L, Núñez M, Blanco F, Clotet B, Sambeat MA, Gil P, Gonzalez-Lahoz J, Cooper D, Soriano V.

AIDS. 2005 Mar 24;19(6):569-75.

PMID:
15802975
13.

Combinations of nucleoside/nucleotide analogues for HIV therapy.

Barreiro P, García-Benayas T, Rendón A, Rodríguez-Novoa S, Soriano V.

AIDS Rev. 2004 Oct-Dec;6(4):234-43. Review.

PMID:
15700622
14.

Short communication: benefits in the lipid profile after substitution of abacavir for Stavudine: a 48-week prospective study.

García-Benayas T, Blanco F, Alcolea A, Cruz JJ, González-Lahoz J, Soriano V.

AIDS Res Hum Retroviruses. 2004 Dec;20(12):1289-92.

PMID:
15650420
15.

Predictors of virological response to atazanavir in protease inhibitor-experienced patients.

Barrios A, Rendón AL, Gallego O, Martín-Carbonero L, Valer L, Ríos P, Maida I, García-Benayas T, Jiménez-Nácher I, González-Lahoz J, Soriano V.

HIV Clin Trials. 2004 Jul-Aug;5(4):201-5.

PMID:
15472794
16.

Changes in mitochondrial DNA copy number in blood cells from HIV-infected patients undergoing antiretroviral therapy.

de Mendoza C, de Ronde A, Smolders K, Blanco F, Garcia-Benayas T, de Baar M, Fernández-Casas P, González-Lahoz J, Soriano V.

AIDS Res Hum Retroviruses. 2004 Mar;20(3):271-3.

PMID:
15117449
17.

Tenofovir-related nephrotoxicity in HIV-infected patients.

Barrios A, García-Benayas T, González-Lahoz J, Soriano V.

AIDS. 2004 Apr 9;18(6):960-3. No abstract available.

PMID:
15060449
18.

Hydroxyurea plus didanosine as maintenance therapy for HIV-infected patients on long-term successful highly active antiretroviral therapy.

Barreiro P, de Mendoza C, Camino N, García-Benayas T, Blanco F, Núñez M, González-Lahoz J, Soriano V.

HIV Clin Trials. 2003 Nov-Dec;4(6):361-71.

PMID:
14628279
19.

Correlation between lopinavir plasma levels and lipid abnormalities in patients taking lopinavir/ritonavir.

González de Requena D, Blanco F, Garcia-Benayas T, Jiménez-Nácher I, González-Lahoz J, Soriano V.

AIDS Patient Care STDS. 2003 Sep;17(9):443-5.

PMID:
14588081
20.

Gynecomastia in HIV-infected patients receiving antiretroviral therapy.

García-Benayas T, Blanco F, Martín-Carbonero L, Valencia E, Barrios A, González-Lahoz J, Soriano V.

AIDS Res Hum Retroviruses. 2003 Sep;19(9):739-41.

PMID:
14585204
Items per page

Supplemental Content

Loading ...
Support Center